Post-approval studies (Phase 4)Study completedNCT01639703What this trial is testingHepatic Xenetix-CT PerfusionWho this might be right forHepatocellular Carcinoma Guerbet 96
Large-scale testing (Phase 3)Looking for participantsNCT06519266What this trial is testingPHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver MetastasesWho this might be right forUveal MelanomaLiver Metastases Vastra Gotaland Region 40
Early research (Phase 1)Not Yet RecruitingNCT07183852What this trial is testingLocoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic MelanomaWho this might be right forMetastatic Uveal MelanomaMetastatic Cutaneous Melanoma Vastra Gotaland Region 18
Large-scale testing (Phase 3)Study completedNCT01785316What this trial is testingThe Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver MetastasesWho this might be right forMelanomaUveal Neoplasms Vastra Gotaland Region 93
Large-scale testing (Phase 3)UnknownNCT04687163What this trial is testingSorafenib or Lenvatinib Plus HAIC of 130 mg/m² Oxaliplatin, and 5-fu vs Sorafenib or Lenvatinib Plus HAIC of 85mg/m² Oxaliplatin, and 5-fu for Unresectable Advanced HCC: a Randomised Phase 3 TrialWho this might be right forHepatocellular Carcinoma Sun Yat-sen University 400
Not applicableUnknownNCT01360892What this trial is testingPrediction of Incidence of Liver Cancer by Use of Real-time Tissue ElastographyWho this might be right forChronic Hepatitis BChronic Hepatitis C Kindai University 1,000
Early research (Phase 1)Looking for participantsNCT07021534What this trial is testingHepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical TrialWho this might be right forPatients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments Zhejiang University 12
Testing effectiveness (Phase 2)Ended earlyNCT06834399What this trial is testingTATE and KN046 in MCRCWho this might be right forColorectal Cancer with Hepatic Metastases Zhejiang Raygene Pharmaceuticals Co., Ltd 42
Not applicableStudy completedNCT02784353What this trial is testingClinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP MalignancyWho this might be right forHepatic NeoplasmsBiliary Tract NeoplasmsPancreatic Neoplasms Asan Medical Center 158
Not applicableWithdrawnNCT02772575What this trial is testingSee if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE)Who this might be right forLiver CancerLiver Metastases Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT02462356What this trial is testingMultiple-portal VATS Versus Uniportal VATS Lobectomy for Non-small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Second Affiliated Hospital, School of Medicine, Zhejiang University 70
Not applicableActive Not RecruitingNCT06248528What this trial is testingComparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.Who this might be right forHepatocellular Carcinoma Chen Xiaoping 1,076
Large-scale testing (Phase 3)Looking for participantsNCT06201065What this trial is testingFOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind TrialWho this might be right forHepatocellular Carcinoma Sun Yat-sen University 200
Testing effectiveness (Phase 2)Ended earlyNCT05220722What this trial is testingPressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver TumorsWho this might be right forHepatocellular CarcinomaIntrahepatic Cholangiocarcinoma TriSalus Life Sciences, Inc. 23
Testing effectiveness (Phase 2)Looking for participantsNCT07145801What this trial is testingY-90 Treatment Response Using Transarterial RadioembolizationWho this might be right forHCCHepatocellular CarcinomaLiver Cancer+3 more Thomas Jefferson University 30
Not applicableUnknownNCT00299299What this trial is testingModelling Internal Hepatic Movement With an External Abdominal MarkerWho this might be right forPatients With Liver Metastases From Colorectal Cancer Royal Marsden NHS Foundation Trust 10
Testing effectiveness (Phase 2)Study completedNCT00223730What this trial is testingChemotherapy Toxicity Reduction Via Urea Cycle SupportWho this might be right forCancer Vanderbilt University 100
Early research (Phase 1)Study completedNCT02070549What this trial is testingTrametinib in Treating Patients With Advanced Cancer With or Without Hepatic DysfunctionWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Solid Neoplasm+1 more National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07012798What this trial is testingFOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma (HCC) Tianjin Medical University Cancer Institute and Hospital 30
Post-approval studies (Phase 4)Study completedNCT01770431What this trial is testingHuaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical HepatectomyWho this might be right forHepatic Carcinoma Qidong Gaitianli Medicines Co., Ltd 1,044